ACETAMINOPHEN; ASPIRIN; CAFFEINE | N020802 | HALEON US HOLDINGS LLC
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 250MG;250MG;65MG
RLD
0 patents0 exclusivities▴
TABLET;ORAL | Approved: Jan 14, 1998
No patent or exclusivity listings for this strength.